drugset / Trial / NCT02172300

Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172300

Phase 3 Completed 198 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to investigate whether tiotropium therapy can increase duration of steady-state exercise by decreasing dynamic and static lung hyperinflation in COPD patients.

Timeline

Start
1999-06
Primary completion
2000-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified Inhaled